Concepts (138)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Natural Language Processing | 7 | 2019 | 436 | 2.12 | Why? |
| United States Department of Veterans Affairs | 8 | 2019 | 553 | 2.09 | Why? |
| Veterans Health | 4 | 2021 | 169 | 1.19 | Why? |
| Veterans | 8 | 2021 | 1131 | 1.12 | Why? |
| Vocabulary | 1 | 2019 | 13 | 0.82 | Why? |
| Software Validation | 1 | 2017 | 5 | 0.71 | Why? |
| Medical Records Systems, Computerized | 1 | 2019 | 159 | 0.69 | Why? |
| Electronic Health Records | 7 | 2020 | 3492 | 0.66 | Why? |
| Carcinoma, Basal Cell | 1 | 2018 | 144 | 0.61 | Why? |
| Adrenergic beta-Antagonists | 1 | 2019 | 465 | 0.60 | Why? |
| Terminology as Topic | 2 | 2020 | 546 | 0.59 | Why? |
| Data Accuracy | 1 | 2018 | 715 | 0.47 | Why? |
| Data Mining | 2 | 2018 | 767 | 0.45 | Why? |
| Echocardiography | 2 | 2018 | 3661 | 0.32 | Why? |
| Skin Neoplasms | 1 | 2018 | 1679 | 0.27 | Why? |
| Databases, Factual | 5 | 2021 | 6248 | 0.22 | Why? |
| Logical Observation Identifiers Names and Codes | 1 | 2020 | 35 | 0.21 | Why? |
| Vocabulary, Controlled | 1 | 2019 | 26 | 0.20 | Why? |
| Angina, Stable | 1 | 2019 | 45 | 0.19 | Why? |
| Intelligence | 1 | 2019 | 89 | 0.19 | Why? |
| Heart Failure | 2 | 2017 | 6638 | 0.19 | Why? |
| Mendelian Randomization Analysis | 1 | 2021 | 317 | 0.18 | Why? |
| Implosive Therapy | 1 | 2018 | 65 | 0.17 | Why? |
| United States | 15 | 2021 | 46150 | 0.17 | Why? |
| Government Agencies | 1 | 2019 | 248 | 0.17 | Why? |
| HIV Infections | 3 | 2018 | 11620 | 0.17 | Why? |
| Stroke Volume | 2 | 2017 | 2153 | 0.16 | Why? |
| Gender Identity | 1 | 2019 | 262 | 0.16 | Why? |
| Pattern Recognition, Automated | 1 | 2017 | 160 | 0.16 | Why? |
| Mycobacterium Infections, Nontuberculous | 1 | 2018 | 167 | 0.15 | Why? |
| Antineoplastic Agents, Hormonal | 1 | 2017 | 203 | 0.15 | Why? |
| Automation | 1 | 2017 | 429 | 0.14 | Why? |
| ErbB Receptors | 1 | 2016 | 320 | 0.14 | Why? |
| Genetic Testing | 1 | 2017 | 395 | 0.14 | Why? |
| DNA Mutational Analysis | 1 | 2016 | 581 | 0.13 | Why? |
| Adverse Drug Reaction Reporting Systems | 1 | 2019 | 694 | 0.13 | Why? |
| Medical Informatics | 1 | 2019 | 648 | 0.11 | Why? |
| Health Services Research | 1 | 2017 | 756 | 0.11 | Why? |
| User-Computer Interface | 1 | 2018 | 1068 | 0.11 | Why? |
| Urinary Bladder Neoplasms | 1 | 2017 | 614 | 0.11 | Why? |
| Algorithms | 2 | 2018 | 7346 | 0.11 | Why? |
| Neoplasm Recurrence, Local | 1 | 2017 | 1063 | 0.10 | Why? |
| Hospitalization | 8 | 2021 | 54280 | 0.10 | Why? |
| Influenza, Human | 4 | 2021 | 10779 | 0.10 | Why? |
| Drug-Related Side Effects and Adverse Reactions | 1 | 2019 | 1261 | 0.09 | Why? |
| Hypertension, Pulmonary | 1 | 2018 | 970 | 0.09 | Why? |
| Patient Readmission | 1 | 2018 | 1543 | 0.09 | Why? |
| Ventricular Function, Left | 1 | 2017 | 1555 | 0.09 | Why? |
| Autoimmune Diseases | 1 | 2021 | 1996 | 0.09 | Why? |
| Feasibility Studies | 1 | 2017 | 3467 | 0.09 | Why? |
| Carcinoma, Non-Small-Cell Lung | 1 | 2016 | 896 | 0.08 | Why? |
| Guideline Adherence | 2 | 2017 | 2309 | 0.08 | Why? |
| Quality of Health Care | 1 | 2019 | 1948 | 0.08 | Why? |
| Patient Care Management | 1 | 2018 | 1514 | 0.08 | Why? |
| Comorbidity | 6 | 2021 | 34796 | 0.08 | Why? |
| Cohort Studies | 8 | 2021 | 36005 | 0.08 | Why? |
| Spain | 5 | 2021 | 15545 | 0.08 | Why? |
| Humans | 25 | 2021 | 930598 | 0.07 | Why? |
| Longitudinal Studies | 2 | 2021 | 9893 | 0.07 | Why? |
| Evidence-Based Medicine | 1 | 2018 | 3228 | 0.07 | Why? |
| Smoking | 1 | 2018 | 3358 | 0.07 | Why? |
| Republic of Korea | 3 | 2021 | 5858 | 0.07 | Why? |
| Female | 15 | 2021 | 380317 | 0.07 | Why? |
| Male | 14 | 2021 | 367725 | 0.07 | Why? |
| Patient Acceptance of Health Care | 2 | 2019 | 5002 | 0.06 | Why? |
| Drug Repositioning | 1 | 2021 | 5683 | 0.06 | Why? |
| Predictive Value of Tests | 1 | 2017 | 9537 | 0.06 | Why? |
| Stress Disorders, Post-Traumatic | 1 | 2018 | 2963 | 0.06 | Why? |
| Machine Learning | 1 | 2018 | 4395 | 0.06 | Why? |
| Prevalence | 5 | 2021 | 25773 | 0.06 | Why? |
| Interleukin-10 Receptor beta Subunit | 1 | 2021 | 111 | 0.06 | Why? |
| Retrospective Studies | 5 | 2019 | 105322 | 0.05 | Why? |
| Aged, 80 and over | 6 | 2021 | 88759 | 0.05 | Why? |
| Obesity | 1 | 2021 | 7388 | 0.05 | Why? |
| Reproducibility of Results | 1 | 2017 | 11304 | 0.05 | Why? |
| Middle Aged | 12 | 2021 | 270681 | 0.05 | Why? |
| Hospitals | 1 | 2019 | 11793 | 0.05 | Why? |
| Lung Neoplasms | 1 | 2016 | 3228 | 0.05 | Why? |
| Breast Neoplasms | 1 | 2017 | 3633 | 0.05 | Why? |
| Quantitative Trait Loci | 1 | 2021 | 340 | 0.05 | Why? |
| Aged | 10 | 2021 | 215776 | 0.05 | Why? |
| Receptor, Interferon alpha-beta | 1 | 2021 | 610 | 0.05 | Why? |
| Decision Making, Computer-Assisted | 1 | 2018 | 61 | 0.05 | Why? |
| Receptors, Progesterone | 1 | 2017 | 76 | 0.04 | Why? |
| Psychotherapy, Group | 1 | 2018 | 134 | 0.04 | Why? |
| Erlotinib Hydrochloride | 1 | 2016 | 48 | 0.04 | Why? |
| Receptors, Estrogen | 1 | 2017 | 171 | 0.04 | Why? |
| Mutation | 1 | 2016 | 12376 | 0.04 | Why? |
| Receptor, ErbB-2 | 1 | 2017 | 267 | 0.04 | Why? |
| Family Therapy | 1 | 2018 | 124 | 0.04 | Why? |
| Intensive Care Units | 2 | 2021 | 29594 | 0.04 | Why? |
| Young Adult | 6 | 2021 | 93724 | 0.03 | Why? |
| Chemotherapy, Adjuvant | 1 | 2017 | 606 | 0.03 | Why? |
| Genome-Wide Association Study | 1 | 2021 | 1648 | 0.03 | Why? |
| Risk Factors | 5 | 2021 | 71621 | 0.03 | Why? |
| Sex Factors | 2 | 2021 | 11014 | 0.03 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.03 | Why? |
| Mastectomy | 1 | 2017 | 536 | 0.03 | Why? |
| Neoplasms | 1 | 2021 | 17251 | 0.03 | Why? |
| Decision Support Systems, Clinical | 1 | 2017 | 551 | 0.03 | Why? |
| CD4 Lymphocyte Count | 1 | 2017 | 1517 | 0.03 | Why? |
| Adult | 8 | 2021 | 244371 | 0.03 | Why? |
| Age Distribution | 1 | 2021 | 3567 | 0.03 | Why? |
| Pulmonary Artery | 1 | 2018 | 803 | 0.03 | Why? |
| Lymph Nodes | 1 | 2017 | 1060 | 0.03 | Why? |
| Psychotherapy | 1 | 2018 | 747 | 0.03 | Why? |
| Risk Reduction Behavior | 1 | 2017 | 946 | 0.02 | Why? |
| Age Factors | 2 | 2021 | 21039 | 0.02 | Why? |
| Data Collection | 1 | 2018 | 1769 | 0.02 | Why? |
| Body Mass Index | 1 | 2021 | 4306 | 0.02 | Why? |
| Symptom Assessment | 1 | 2021 | 4967 | 0.02 | Why? |
| Adolescent | 3 | 2021 | 86841 | 0.02 | Why? |
| Diagnosis, Differential | 1 | 2021 | 7220 | 0.02 | Why? |
| Prognosis | 2 | 2021 | 32490 | 0.02 | Why? |
| Germany | 1 | 2021 | 9196 | 0.02 | Why? |
| France | 1 | 2021 | 12074 | 0.02 | Why? |
| Proportional Hazards Models | 1 | 2017 | 6543 | 0.02 | Why? |
| Anti-HIV Agents | 1 | 2017 | 2209 | 0.02 | Why? |
| Survival Analysis | 1 | 2016 | 7592 | 0.02 | Why? |
| Disease Progression | 1 | 2021 | 13580 | 0.01 | Why? |
| Pneumonia, Viral | 2 | 2020 | 243684 | 0.01 | Why? |
| Child | 2 | 2021 | 70012 | 0.01 | Why? |
| Coronavirus Infections | 2 | 2020 | 253789 | 0.01 | Why? |
| Aging | 1 | 2018 | 3581 | 0.01 | Why? |
| United Kingdom | 1 | 2021 | 18046 | 0.01 | Why? |
| Antineoplastic Agents | 1 | 2016 | 3550 | 0.01 | Why? |
| Infant, Newborn | 1 | 2021 | 23105 | 0.01 | Why? |
| Pandemics | 3 | 2021 | 389249 | 0.01 | Why? |
| Infant | 1 | 2021 | 30274 | 0.01 | Why? |
| Case-Control Studies | 1 | 2017 | 17671 | 0.01 | Why? |
| Time Factors | 1 | 2021 | 31397 | 0.01 | Why? |
| Child, Preschool | 1 | 2021 | 36283 | 0.01 | Why? |
| Viral Load | 1 | 2017 | 15850 | 0.01 | Why? |
| Betacoronavirus | 1 | 2020 | 204454 | 0.01 | Why? |
| Treatment Outcome | 1 | 2021 | 51732 | 0.01 | Why? |
| Risk Assessment | 1 | 2017 | 25439 | 0.01 | Why? |
| Prospective Studies | 1 | 2018 | 43301 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2019 | 48226 | 0.01 | Why? |
DuVall's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(138)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(234)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_